Everforth Inc quarterly report, Q3 FY2005

Business Context and Reporting Period

Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2005
Business Overview: A diversified professional staffing firm operating in two segments: Healthcare Staffing (Nurse Travel and Medical Financial & Allied) and Lab Support (Life sciences staffing). The company provides temporary, temporary-to-permanent, and direct placement services.

Key Financial Metrics

Metric Three Months Ended Sep 30, 2005 Nine Months Ended Sep 30, 2005
Revenues $65,951,000 $173,155,000
Gross Profit $17,941,000 $46,245,000
Gross Margin 27.2% 26.7%
Operating Income (Loss) $1,576,000 $(1,650,000)
Net Income (Loss) $1,808,000 $(917,000)
Diluted EPS $0.07 $(0.04)
Cash and Cash Equivalents $20,425,000 $20,425,000 (Ending Balance)
Restricted Cash $4,878,000 $4,878,000 (Ending Balance)
Total Assets $93,981,000 $93,981,000 (Ending Balance)
Total Liabilities $19,252,000 $19,252,000 (Ending Balance)
Working Capital $44,769,000 $44,769,000 (Ending Balance)

Material Changes vs. Prior Period

  • Revenue Growth: Revenues increased 33.1% year-over-year (YoY) for the quarter and 21.7% for the nine-month period. Growth was driven by a 20.6% increase in the average number of professionals on assignment and a 7.4% increase in average bill rates for the quarter.
  • Profitability Turnaround: The company reported a net income of $1.8 million for the quarter, a significant improvement from a net loss of $32.2 million in the same period in 2004. The prior year loss included $26.4 million in goodwill impairment and $3.9 million in identifiable intangible asset impairment, neither of which occurred in 2005.
  • Expense Management: Selling, General, and Administrative (SG&A) expenses decreased 13.1% YoY for the quarter ($16.4M vs $18.8M), primarily due to reduced corporate restructuring charges and lower consulting/legal fees.
  • Cash Flow: Net cash provided by operating activities was $3.4 million for the nine months ended September 30, 2005, compared to a use of $3.8 million in the prior year period. This improvement was aided by a $5.7 million income tax refund.

Guidance, Outlook, and Risks

  • Outlook: Management expects continued year-over-year revenue growth in the fourth quarter of 2005, assuming stable demand. Gross margins are expected to decrease slightly in Q4 due to seasonality (holiday incentives) and service mix changes.
  • Strategic Focus: The company is focusing on operational execution, expanding direct placements, and growing newer service lines including Health Information Management (HIM), Local Nursing, Engineering, and Clinical Research.
  • Liquidity: The company maintains strong liquidity with $25.3 million in cash, cash equivalents, and restricted cash. No borrowing facility is currently in place, though management believes one could be secured if needed.
  • Accounting Changes: The company must adopt FAS 123R (Share-Based Payment) in Q1 2006, which will require recognizing stock-based compensation expense based on fair value. The impact is currently being evaluated.
  • Risks: Key risks include demand for services, ability to retain qualified staff, competition, and the outcome of an ongoing IRS audit of 2003 and 2004 tax returns (management does not expect a material effect).

Investor Verification Checklist

  • Segment Performance: Verify the sustainability of the 46.9% revenue growth in the Nurse Travel segment, which is noted as having lower margins than other lines.
  • Workers' Compensation Liability: Review the $4.1 million accrued liability for workers' compensation and the $4.9 million in restricted cash collateralizing letters of credit for this self-insured program.
  • Valuation Allowance: Confirm the status of the full valuation allowance against deferred income tax assets, which prevents the recognition of federal tax benefits despite current profitability.
  • Accounts Receivable: Monitor the $35 million accounts receivable balance, which increased significantly ($8.3 million) during the nine-month period, impacting operating cash flow.
  • Goodwill Impairment: Note that while no impairment occurred in 2005, the company holds $16.6 million in goodwill and must test for impairment annually or upon triggering events.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.